DA Davidson Comments on Clorox's FY2026 Earnings (NYSE:CLX)

The Clorox Company (NYSE:CLX - Free Report) - Equities researchers at DA Davidson increased their FY2026 EPS estimates for Clorox in a research report issued on Monday, November 4th. DA Davidson analyst L. Weiser now forecasts that the company will earn $6.61 per share for the year, up from their previous forecast of $6.31. DA Davidson has a "Neutral" rating and a $171.00 price target on the stock. The consensus estimate for Clorox's current full-year earnings is $6.81 per share.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the company posted $0.49 EPS. The company's revenue was up 27.0% compared to the same quarter last year.

A number of other equities research analysts have also commented on CLX. BNP Paribas upgraded Clorox to a "strong sell" rating in a research report on Friday, September 6th. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research note on Friday, November 1st. JPMorgan Chase & Co. lifted their target price on shares of Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a research note on Friday, October 11th. Wells Fargo & Company cut their price target on Clorox from $135.00 to $130.00 and set an "underweight" rating for the company in a research note on Wednesday, July 10th. Finally, Evercore ISI decreased their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research report on Monday, October 14th. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $155.00.

Clorox Trading Up 0.2 %

Shares of NYSE:CLX traded up $0.28 during mid-day trading on Wednesday, hitting $162.70. The stock had a trading volume of 1,731,057 shares, compared to its average volume of 1,245,675. The company's 50 day moving average is $161.89 and its 200-day moving average is $146.58. Clorox has a 12-month low of $127.60 and a 12-month high of $169.09. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company has a market cap of $20.14 billion, a PE ratio of 56.69, a P/E/G ratio of 3.11 and a beta of 0.41.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.00%. Clorox's dividend payout ratio (DPR) is presently 170.03%.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.57% of the stock is owned by company insiders.

Institutional Trading of Clorox

Institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Clorox by 0.3% during the first quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company's stock valued at $2,339,150,000 after purchasing an additional 48,632 shares in the last quarter. Mizuho Securities USA LLC grew its position in Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after acquiring an additional 4,490,421 shares during the period. Nuance Investments LLC raised its stake in Clorox by 150.6% during the second quarter. Nuance Investments LLC now owns 1,597,674 shares of the company's stock worth $218,035,000 after acquiring an additional 960,094 shares in the last quarter. Van ECK Associates Corp lifted its holdings in shares of Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock valued at $237,372,000 after acquiring an additional 31,510 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Clorox by 14.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 961,387 shares of the company's stock valued at $131,200,000 after purchasing an additional 120,716 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.